Skip to main content
Livermore
Livermore
ZHEN

Eudaimonia Advisors LLC

SEC CIK
0001905084
Latest filing
Apr 25, 2024

The latest 13F from Eudaimonia Advisors LLC covers Q1 2024 (filed Apr 25, 2024): 161 long positions worth $187.8M. The top 10 holdings make up 29.9% of the portfolio, and the largest is Lamar Advertising Co (LAMR) at 6.8%. Livermore has 10 filings on Form 13F from this institution, going back to Q4 2021.

What changed in Q1 2024

Share counts compared with Q4 2023: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
23
Est. +$13.4M
Added
75
Est. +$17.0M
Reduced
49
Est. −$6.07M
Sold out
6
Est. −$2.80M

Top 5 holdings

Share of this quarter's portfolio value

  1. LAMRLamar Advertising Co
    6.8%$12.8MHistory
  2. Schwab US Dividend Equity ETF808524797
    3.9%$7.31M
  3. AAPLApple Inc.
    3.2%$6.02MHistory
  4. MSFTMicrosoft Corp
    3.0%$5.66MHistory
  5. Vanguard Information Technology ETF92204A702
    2.5%$4.67M

Biggest buys

New and added positions, by estimated amount bought

  1. NVONovo Nordisk A S
    +$3.68MNewHistory
  2. WisdomTree Tr97717X669
    +$2.82MAdded
  3. Invesco Exch Traded FD Tr II46138G599
    +$1.57MNew
  4. Vanguard Information Technology ETF92204A702
    +$1.31MAdded
  5. Vanguard Consumer Staples ETF92204A207
    +$1.05MAdded

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. NVONovo Nordisk A S
    +1.96 pp0.0% → 2.0%History
  2. WisdomTree Tr97717X669
    +1.47 pp0.3% → 1.8%
  3. Invesco Exch Traded FD Tr II46138G599
    +0.83 pp0.0% → 0.8%
  4. GBTCGrayscale Bitcoin Trust ETF
    +0.53 pp0.0% → 0.5%History
  5. Vanguard Consumer Staples ETF92204A207
    +0.52 pp0.3% → 0.8%

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. Schwab US Dividend Equity ETF808524797
    −$928.2KReduced
  2. iShares Select U.S. REIT ETF464287564
    −$845.8KSold out
  3. PFEPfizer Inc
    −$771.9KReducedHistory
  4. J P Morgan Exchange Traded F46641Q332
    −$538.8KReduced
  5. iShares Tr464287440
    −$487.6KSold out

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. Schwab US Dividend Equity ETF808524797
    −1.14 pp5.0% → 3.9%
  2. PFEPfizer Inc
    −0.58 pp0.8% → 0.2%History
  3. LAMRLamar Advertising Co
    −0.57 pp7.4% → 6.8%History
  4. iShares Select U.S. REIT ETF464287564
    −0.55 pp0.5% → 0.0%
  5. J P Morgan Exchange Traded F46641Q332
    −0.43 pp1.1% → 0.7%

Metrics

13F metrics for Q1 2024, computed only from the numbers in the filings. Definitions below.

Portfolio value
$187.8M
+$33.2M (+21.5%) vs. prior quarter
Positions
161
+17 vs. prior quarter
Top 10 concentration
29.9%
Top 10 as share of value
Turnover
5.2%
Q1 2024, one quarter
Average holding period
8.5 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q4 2021), so positions held before then are understated.

13F filings by quarter

10 quarters, going back to Q4 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $187.8M (Q1 2024)

Q4 2021: $170.0MQ1 2022: $173.9MQ2 2022: $145.5MQ3 2022: $138.3MQ4 2022: $147.2MQ1 2023: $148.3MQ2 2023: $149.0MQ3 2023: $142.3MQ4 2023: $154.6MQ1 2024: $187.8M
Q4 2021Q1 2024
13F filings of Eudaimonia Advisors LLC by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q1 2024Apr 25, 2024161$187.8MLAMRSchwab US Dividend Equity ETFAAPLvs. Q4 2023SEC
Q4 2023Feb 1, 2024144$154.6MLAMRSchwab US Dividend Equity ETFAAPLvs. Q3 2023SEC
Q3 2023Oct 24, 2023141$142.3MLAMRSchwab US Dividend Equity ETFAAPLvs. Q2 2023SEC
Q2 2023Jul 19, 2023145$149.0MLAMRSchwab US Dividend Equity ETFAAPLvs. Q1 2023SEC
Q1 2023Apr 25, 2023150$148.3MLAMRSchwab US Dividend Equity ETFAAPLvs. Q4 2022SEC
Q4 2022Jan 24, 2023146$147.2MLAMRSchwab US Dividend Equity ETFState Street SPDR Bloomberg 1-3 Month T-Bill ETFvs. Q3 2022SEC
Q3 2022Nov 4, 2022144$138.3MLAMRSchwab Strategic TrState Street SPDR Bloomberg 1-3 Month T-Bill ETFvs. Q2 2022SEC
Q2 2022Aug 9, 2022151$145.5MLAMRSchwab US Dividend Equity ETFSchwab Strategic Trvs. Q1 2022SEC
Q1 2022May 16, 2022162$173.9MLAMRPIMCO Enhanced Short Maturity Active Exchange-Traded FundSchwab US Dividend Equity ETFvs. Q4 2021SEC
Q4 2021Feb 14, 2022165$170.0MLAMRInvesco Exchange Traded FD TSchwab US Dividend Equity ETF–SEC